Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

N-Valeric Acid

Home DrugsN-Valeric Acid

Experimental

Small Molecule

N-Valeric Acid

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₅H₁₀O₂
CAS Number: 109-52-4
UNII ID: GZK92PJM7B

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same
US 2002164726 A1Applicant: KENMOKU TAKASHIPriority: 2001
US
4 publications
N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use
US 6887952 B1Applicant: BIOSITE INCPriority: 2004
US
4 publications
Pharmaceutical composition comprising (1r,4r)-6-fluoro-N, N-dimethyl-4-phenyl-4,9-dihydro-3H-spiro[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US 9345689 B2Applicant: GRUENENTHAL GMBHPriority: 2013
CN
US
3 publications
MOSQUITO REPELLENT SOLUTION, PREPARATION METHOD AND USE THEREOF
US 2012045525 A1Applicant: MA JIANYIPriority: 2008
US
Paraquat hapten, paraquat complete antigen and preparation method of paraquat hapten and paraquat complete antigen
CN 103130712 AApplicant: INST HYGIENE & ENVIRONMETNAL MEDICINE ACADEMY MILITARY MEDICAL SCIENCESPriority: 2011
CN
Method for preparing high-purity butyphthalide
CN 110003154 AApplicant: HEBEI ZHI HENG PHARMACY TECH CO LTDPriority: 2019
CN
Preparation method of (S)-2-((9H-fluoren-9-methoxycarbonyl)methylamino)-5-amino-5-oxovaleric acid
CN 112174854 AApplicant: SHANGHAI JIFENG BIOTECHNOLOGY CO LTDPriority: 2020
CN
Antibiotic compounds, formulations and methods of use
CN 118871454 AApplicant: UNIV LEIDENPriority: 2022
CN
Non-starch avicennia marina total polysaccharide, preparation method thereof and application of non-starch avicennia marina total polysaccharide as intestinal prebiotics
CN 114524886 AApplicant: GUANGXI TRADITIONAL CHINESE MEDICINE UNIVPriority: 2022
CN
Synthesis process of 5-n-propyl hydantoin
CN 116715635 AApplicant: HEBEI XINTAOYUAN MEDICINE TECH CO LTDPriority: 2023
CN

Page 1 of 2